Since Mr. Reed has urged us to follow the money trail, and after my talk with the banker last week, I was pleased to see that others are looking at ethical stem cells as an investment.
The business journal, Bloomberg, reported on several companies that are involved in ethical stem cell research. Evidently, these companies received a boost in their ratings after the news of amniotic stem cells broke over the weekend.
(HT to Rush Limbaugh)
Wednesday, January 10, 2007
The business of adult stem cells
Posted by LifeEthics.org at 7:30 AM
Labels: medical ethics, medical finance, research finance, stem cell research, stem cells
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment